Inventor · disambiguated record
Helene Baribault
Also filed as: BARIBAULT HELENE · BARIBAULT HÉLÈNE
8 granted patents·9 pending applications·9 citations·filing 2001–2025
79Inventor score
Top patents by PatentIndex Score
17 records- 0191US12240876B2Liver-specific Wnt signal enhancing molecules and uses thereofSURROZEN OPERATING INC·Filed 2023·Granted Mar 4, 2025·1 cites·10 claims
- 0291US10793568B2Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2017·Granted Oct 6, 2020·4 cites·1 claims
- 0385US2025115608A1Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2024·Application pending·0 cites
- 0480US11091482B2Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activatorsARDELYX INC·Filed 2017·Granted Aug 17, 2021·3 cites·1 claims
- 0578US12297278B2Wnt surrogate molecules and uses thereofSURROZEN OPERATING INC·Filed 2023·Granted May 13, 2025·0 cites·5 claims
- 0677US12209088B2Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2022·Granted Jan 28, 2025·0 cites·20 claims
- 0775US11773171B2WNT surrogate molecules and uses thereofSURROZEN OPERATING INC·Filed 2018·Granted Oct 3, 2023·1 cites·10 claims
- 0869US2025223368A1Wnt surrogate molecules and uses thereofSURROZEN OPERATING INC·Filed 2025·Application pending·0 cites
- 0968US2021017177A1Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2020·Application pending·0 cites
- 1063US11718619B2Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activatorsARDELYX INC·Filed 2021·Granted Aug 8, 2023·0 cites·4 claims
- 1159US2025171509A1Liver-specific wnt signal enhancing molecules and uses thereofSURROZEN OPERATING INC·Filed 2025·Application pending·0 cites
- 1248US12466884B2Tissue-specific WNT signal enhancing molecules and usesSURROZEN OPERATING INC·Filed 2019·Granted Nov 11, 2025·0 cites·11 claims
- 1345US2022195053A1Modulation of wnt signaling in gastrointestinal disordersSURROZEN OPERATING INC·Filed 2020·Application pending·0 cites
- 1442US2006137031A1Transgenic mice containing retinoid X receptor interacting protein gene disruptionsALLEN KEITH D·Filed 2006·Application pending·0 cites
- 1541US2014189893A1Method of identifying compounds that specifically modulate the interaction of fgfr1 and beta klothoLI YANG·Filed 2012·Application pending·0 cites
- 1641US2002137203A1Transgenic mice containing alpha-endosulfine gene disruptionsFiled 2001·Application pending·0 cites
- 1736US2002116731A1Transgenic mice containing retinoid X receptor interacting protein gene disruptionsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →